Manipulation of the tumor suppressor p53 for potentiating cancer therapy

被引:33
|
作者
Haupt, S
Haupt, Y [1 ]
机构
[1] Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmaceut, IL-91120 Jerusalem, Israel
[2] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91120 Jerusalem, Israel
基金
以色列科学基金会;
关键词
p53; Mdm2; therapy; DNA damage; small molecules;
D O I
10.1016/j.semcancer.2004.04.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor suppressor p53 is a linchpin in the regulation of appropriate cellular responses to various stress conditions. Inactivation of the functions of this critical participant can have diabolical consequences, in particular the development of malignant diseases. Elicitation of appropriate p53 functions is an attractive strategy for combating cancer. Triggering p53 responses, reconstituting p53 activities through gene therapy, coercing mutant p53 to perform normal functions, manipulating p53 regulators, and activating p53 effectors are all approaches that are currently being developed. Here, we will overview 'p53-based' strategies for fighting cancer, both those under clinical trial and recent innovative concepts. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:244 / 252
页数:9
相关论文
共 50 条
  • [1] The tumor suppressor p53 - Cancer and aging
    Feng, Zhaohui
    Hu, Wenwei
    Rajagopal, Gunaretnam
    Levine, Arnold J.
    CELL CYCLE, 2008, 7 (07) : 842 - 847
  • [2] APOPTOSIS, CANCER AND THE P53 TUMOR-SUPPRESSOR GENE
    LEE, JM
    BERNSTEIN, A
    CANCER AND METASTASIS REVIEWS, 1995, 14 (02) : 149 - 161
  • [3] The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death
    Chari, Nikhil S.
    Pinaire, Nicole L.
    Thorpe, Lynnelle
    Medeiros, L. Jeffrey
    Routbort, Mark J.
    McDonnell, Timothy J.
    APOPTOSIS, 2009, 14 (04) : 336 - 347
  • [4] Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities
    Hong, Bo
    van den Heuvel, A. Pieter J.
    Prabhu, Varun V.
    Zhang, Shengliang
    El-Deiry, Wafik S.
    CURRENT DRUG TARGETS, 2014, 15 (01) : 80 - 89
  • [5] THE P53 TUMOR-SUPPRESSOR GENE IN BREAST-CANCER
    ELLEDGE, RM
    ALLRED, DC
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 32 (01) : 39 - 47
  • [6] Tumor suppressor p53 and metabolism
    Liu, Juan
    Zhang, Cen
    Hu, Wenwei
    Feng, Zhaohui
    JOURNAL OF MOLECULAR CELL BIOLOGY, 2019, 11 (04) : 284 - 292
  • [7] Alterations in p53 tumor suppressor gene in lung cancer
    Zalcman, G
    Soussi, T
    REVUE DES MALADIES RESPIRATOIRES, 2000, 17 (01) : 329 - 349
  • [8] Tumor suppressor p53 and its mutants in cancer metabolism
    Liu, Juan
    Zhang, Cen
    Hu, Wenwei
    Feng, Zhaohui
    CANCER LETTERS, 2015, 356 (02) : 197 - 203
  • [9] The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death
    Nikhil S. Chari
    Nicole L. Pinaire
    Lynnelle Thorpe
    L. Jeffrey Medeiros
    Mark J. Routbort
    Timothy J. McDonnell
    Apoptosis, 2009, 14 : 336 - 347
  • [10] Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
    Graupner, Vilma
    Schulze-Osthoff, Klaus
    Essmann, Frank
    Jaenicke, Reiner U.
    CELL CYCLE, 2009, 8 (08) : 1238 - 1248